LOXITANE IM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Loxitane Im, and when can generic versions of Loxitane Im launch?
Loxitane Im is a drug marketed by Actavis Labs Ut Inc and is included in one NDA.
The generic ingredient in LOXITANE IM is loxapine hydrochloride. There are eight drug master file entries for this compound. Additional details are available on the loxapine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LOXITANE IM?
- What are the global sales for LOXITANE IM?
- What is Average Wholesale Price for LOXITANE IM?
Summary for LOXITANE IM
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 13 |
Clinical Trials: | 1 |
Patent Applications: | 382 |
DailyMed Link: | LOXITANE IM at DailyMed |
Recent Clinical Trials for LOXITANE IM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Mylan Pharmaceuticals | Phase 1 |
US Patents and Regulatory Information for LOXITANE IM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Actavis Labs Ut Inc | LOXITANE IM | loxapine hydrochloride | INJECTABLE;INJECTION | 018039-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LOXITANE IM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Actavis Labs Ut Inc | LOXITANE IM | loxapine hydrochloride | INJECTABLE;INJECTION | 018039-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LOXITANE IM
See the table below for patents covering LOXITANE IM around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Brazil | 6457122 | ⤷ Sign Up | |
Switzerland | 450422 | Verfahren zur Herstellung 11-basisch substituierter Dibenz(b,f)(1,4)oxazepine | ⤷ Sign Up |
Switzerland | 485765 | Verfahren zur Herstellung basisch substituierter Heterocyclen | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for LOXITANE IM
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1389098 | 300609 | Netherlands | ⤷ Sign Up | PRODUCT NAME: LOXAPINE; REGISTRATION NO/DATE: EU/1/13/823/001-002 20130220 |
1389098 | 2013C/054 | Belgium | ⤷ Sign Up | PRODUCT NAME: LOXAPINE; AUTHORISATION NUMBER AND DATE: EU/1/13/823/001 20130225 |
1389098 | C300609 | Netherlands | ⤷ Sign Up | PRODUCT NAME: LOXAPINE; REGISTRATION NO/DATE: EU/1/13/823/001-002 20130220 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |